Adrenal Hypercortisolism: A Closer Look at Screening, Diagnosis, and Important Considerations of Different Testing Modalities
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Although prolonged hypercortisolism is associated with increased mortality and substantial morbidity, the clinical signs and symptoms are wide ranging and often nonspecific, contributing to challenges in diagnosis, as well as treatment delays. Greater awareness is needed among clinicians to help identify which patients should undergo biochemical screening for excess cortisol. Several biochemical tests are available, each with important caveats that should be considered in the context of the individual patient. Cortisol secretion varies widely, further complicating the biochemical diagnosis of hypercortisolism, which relies on the use of definitive cutoff values. Patients with hypercortisolism resulting from adrenal adenomas, including those discovered incidentally, often do not present with overt Cushingoid features (plethora, striae, muscle weakness, moon facies, etc.). However, the consequences of prolonged exposure to even slight elevations in cortisol levels are profound, including increased risk of diabetes, hypertension, fractures, cardiovascular events, and mortality. Because most cases of hypercortisolism resulting from an adrenal adenoma can be managed, it is imperative to identify patients at risk and initiate testing early for the best outcomes. The aim of this report is to increase awareness of the indications for screening for hypercortisolism and to review the biochemical screening tests and diagnosis for hypercortisolism associated with adrenal adenomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EIA-F, LCMS-F, or LCMS-E have poor sensitivity for the diagnosis of cortisol excess in patients with adrenal incidentalomas and/or mild cortisol excess [56, 65, 74]”
From Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome (2020) · cites this paper as [74]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 10×
“Patients with newly discovered adrenal adenomas and/or signs and symptoms leading to a suspicion of hypercortisolism should undergo biochemical screening [11].”
BackgroundMethodInfluentialFassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · cited 5×
“Whereas the most recent clinical guidelines regarding diagnosis of hypercortisolism in patients with adrenal incidentalomas, from 2016, suggest that patients undergo screening with the ODST [8], a recent study of 57 centers from 26 European countries found that testing protocols varied considerably across practices [5…”
BackgroundInfluentialTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
OMURA, M., SAITO, J., YAMAGUCHI, K., KAKUTA, Y., & NISHIKAWA, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.193 · Cited by 562 · cited 1×
“The prevalence of hypercortisolism in the general hypertensive patient population has been reported as ;1% [22], although a higher rate (8%) has been reported in patients with resistant hypertension (i.”
BackgroundCharacterization of the normal temporal pattern of plasma corticosteroid levels.
KRIEGER, D. T., ALLEN, W., RIZZO, F., & KRIEGER, H. P. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-2-266 · Cited by 549 · cited 1×
“Cortisol levels are expected to peak upon awakening in the morning (0700 to 0900 hours) and taper off during the day and are at their lowest during the late night (2300 to 0100 hours) [31, 32].”
BackgroundDi Dalmazi, G., Vicennati, V., Garelli, S., Casadio, E., Rinaldi, E., Giampalma, E., Mosconi, C., Golfieri, R., Paccapelo, A., Pagotto, U., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70211-0 · Cited by 415
Valassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0272 · Cited by 402
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390
Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee
Mayo-Smith, W. W., Song, J. H., Boland, G. L., Francis, I. R., Israel, G. M., Mazzaglia, P. J., Berland, L. L., & Pandharipande, P. V. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.05.001 · Cited by 362 · cited 1×
“Various radiology and clinical guidelines have suggested routine clinical and hormonal workup for incidentally discovered adrenal adenomas [12].”
BackgroundTannenbaum, C., Clark, J., Schwartzman, K., Wallenstein, S., Lapinski, R., Meier, D., & Luckey, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020275 · Cited by 314
The relationship between smoking status and cortisol secretion.
Badrick, E., Kirschbaum, C., & Kumari, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2155 · Cited by 284
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
Self-citationSalivary cortisol sampling compliance: comparison of patients and healthy volunteers
Broderick, J. E., Arnold, D., Kudielka, B. M., & Kirschbaum, C. (2004) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00093-3 · Cited by 261 · cited 1×
“Nonetheless, adherence to the timing of sample collection has been shown to be an issue [40].”
BackgroundRisk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 254 · cited 1×
“Because progression to overt Cushing syndrome is relatively rare [6, 7], these patients are often described separately as having “subclinical Cushing syndrome.”
BackgroundLong-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
Self-citationNilsson, I. M., & Holmberg, L. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91962-x · Cited by 212
Late-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194
Wood, P. J., Barth, J. H., Freedman, D. B., Perry, L., & Sheridan, B. (1997) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329703400302 · Cited by 190
Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186 · cited 1×
“Furthermore, the sample can be stored in the refrigerator for several days and mailed to the laboratory at room temperature [11, 38, 39].”
BackgroundMortality and morbidity in Cushing's syndrome in New Zealand
Bolland, M. J., Holdaway, I. M., Berkeley, J. E., Lim, S., Dransfield, W. J., Conaglen, J. V., Croxson, M. S., Gamble, G. D., Hunt, P. J., & Toomath, R. J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04124.x · Cited by 182
The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome
Findling, J. W., Raff, H., & Aron, D. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030207 · Cited by 165 · cited 1×
“Whereas some clinicians have cited a historic cutoff of #5 mg/dL (138 nM) as “normal,” the use of this historic cutoff misclassified up to 15% of patients with false-negative results [6, 28].”
BackgroundSubclinical hypercortisolism among outpatients referred for osteoporosis.
Chiodini, I., Mascia, M. L., Muscarella, S., Battista, C., Minisola, S., Arosio, M., Santini, S. A., Guglielmi, G., Carnevale, V., & Scillitani, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00006 · Cited by 162 · cited 2×
“Screening may also be considered in patients with greater than expected declines in BMD or with BMD that is resistant to treatment [27].”
BackgroundSelf-citationRaff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141 · cited 5×
“As a result of the lower specificity and sensitivity comparedwith othermethods, especially for less severe disease, the use of this test is secondary to other testing assays [9].”
BackgroundResultInfluentialGlucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140 · cited 1×
“Chronic hypercortisolism, even in the so-called “subclinical” stage, can have pleiotropic effects onmajor peripheral tissues responsible for glucose homeostasis [18].”
BackgroundNunes, M.-L., Vattaut, S., Corcuff, J.-B., Rault, A., Loiseau, H., Gatta, B., Valli, N., Letenneur, L., & Tabarin, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1542 · Cited by 129 · cited 1×
“However, it could be used as a confirmative test if the first results are abnormal [34, 36, 37].”
BackgroundDiagnosis and Differential Diagnosis of Cushing’s Syndrome
Loriaux, D. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1505550 · Cited by 127
Masserini, B., Morelli, V., Bergamaschi, S., Ermetici, F., Eller-Vainicher, C., Barbieri, A. M., Maffini, M. A., Scillitani, A., Ambrosi, B., Beck-Peccoz, P., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0485 · Cited by 106 · cited 1×
“However, it could be used as a confirmative test if the first results are abnormal [34, 36, 37].”
BackgroundSelf-citationGuignat, L., & Bertherat, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0627 · Cited by 101
TSUIKI, M., TANABE, A., TAKAGI, S., NARUSE, M., & TAKANO, K. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-177 · Cited by 97
Pitfalls in the diagnosis and management of Cushing's syndrome
Bansal, V., Asmar, N. E., Selman, W. R., & Arafah, B. M. (2015) · Neurosurgical Focus · doi:10.3171/2014.11.focus14704 · Cited by 81
Dennedy, M. C., Annamalai, A. K., Prankerd Smith, O., Freeman, N., Vengopal, K., Graggaber, J., Koulouri, O., Powlson, A. S., Shaw, A., Halsall, D. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2718 · Cited by 81 · cited 2×
“Low-serumDHEAS levels have been shown to be a marker of excess cortisol in patients with adrenal adenomas (ACTH-independent hypercortisolism) [50, 52].”
BackgroundUrine Free cortisol in the diagnosis of cushing’s syndrome: Is It worth doing and, If so, how?
Raff, H., Auchus, R. J., Findling, J. W., & Nieman, L. K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3766 · Cited by 68 · cited 1×
“because the dysregulated and increased production of cortisol does not typically exceed the plasma-binding capacity of free cortisol, limiting the appearance of cortisol in the urine [46].”
BackgroundInternal dissociation of the circadian markers of the cortisol rhythm in night workers
Weibel, L., Spiegel, K., Follenius, M., Ehrhart, J., & Brandenberger, G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.4.e608 · Cited by 68 · cited 1×
“Another confounder is that normal circadian rhythms are disrupted in persons with altered sleep patterns, such as shift workers, which causes abnormally elevated levels [41].”
BackgroundMartins, L. C., Conceição, F. L., Muxfeldt, E. S., & Salles, G. F. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283521484 · Cited by 61 · cited 1×
“, uncontrolled with three antihypertensives, including a diuretic) [23].”
BackgroundDHEAS for the prediction of subclinical Cushing’s syndrome: perplexing or advantageous?
Yener, S., Yilmaz, H., Demir, T., Seçil, M., & Çömlekçi, A. (2014) · Endocrine · doi:10.1007/s12020-014-0387-7 · Cited by 60 · cited 10×
“In ACTH-independent hypercortisolism, the negative-feedback suppression of pituitary corticotrophs by cortisol leads to reduced plasma ACTH levels.”
BackgroundInfluentialGuignard, M. M., Pesquies, P. C., Serrurier, B. D., Merino, D. B., & Reinberg, A. E. (1980) · Acta Endocrinologica · doi:10.1530/acta.0.0940536 · Cited by 58
Diagnostic tests for Cushing’s syndrome differ from published guidelines: data from ERCUSYN
Valassi, E., Franz, H., Brue, T., Feelders, R. A., Netea-Maier, R., Tsagarakis, S., Webb, S. M., Yaneva, M., Reincke, M., Droste, M., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0967 · Cited by 58 · cited 1×
“Whereas the most recent clinical guidelines regarding diagnosis of hypercortisolism in patients with adrenal incidentalomas, from 2016, suggest that patients undergo screening with the ODST [8], a recent study of 57 centers from 26 European countries found that testing protocols varied considerably across practices [5…”
BackgroundSereg, M., Tőke, J., Patócs, A., Varga, I., Igaz, P., Szücs, N., Horányi, J., Pusztai, P., Czirják, S., Gláz, E., et al. (2011) · Steroids · doi:10.1016/j.steroids.2010.08.007 · Cited by 53 · cited 1×
“However, it could be used as a confirmative test if the first results are abnormal [34, 36, 37].”
BackgroundFrom first symptoms to final diagnosis of Cushing's disease: experiences of 176 patients
Kreitschmann-Andermahr, I., Psaras, T., Tsiogka, M., Starz, D., Kleist, B., Siegel, S., Milian, M., Kohlmann, J., Menzel, C., Führer-Sakel, D., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0766 · Cited by 53 · cited 2×
“In addition, although 83% of patients initially go to their family physician to address their symptoms, almost 70% of patients ultimately are diagnosed by an endocrinologist, and substantial differences are observed between the number of consulted physicians in rural and urban places of living, suggesting differences…”
BackgroundSix controversial issues on subclinical Cushing’s syndrome
on behalf of the ABC Group, Chiodini, I., Albani, A., Ambrogio, A. G., Campo, M., Martino, M. C. D., Marcelli, G., Morelli, V., Zampetti, B., Colao, A. A. L., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1017-3 · Cited by 52
Self-citationDehydroepiandrosterone Sulfate in the Assessment of the Hypothalamic-Pituitary-Adrenal Axis
Fischli, S., Jenni, S., Allemann, S., Zwahlen, M., Diem, P., Christ, E. R., & Stettler, C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1780 · Cited by 51 · cited 11×
“In ACTH-independent hypercortisolism, the negative-feedback suppression of pituitary corticotrophs by cortisol leads to reduced plasma ACTH levels.”
BackgroundInfluentialPrevalence of subclinical contributors to low bone mineral density and/or fragility fracture
Eller-Vainicher, C., Cairoli, E., Zhukouskaya, V. V., Morelli, V., Palmieri, S., Scillitani, A., Beck-Peccoz, P., & Chiodini, I. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0102 · Cited by 49
Self-citationSteffensen, C., Pereira, A. M., Dekkers, O. M., & Jørgensen, J. O. L. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0434 · Cited by 39
Variability of late-night salivary cortisol in Cushing disease: a prospective study
Sandouk, Z., Johnston, P., Bunch, D., Wang, S., Bena, J., Hamrahian, A., & Kennedy, L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02020 · Cited by 39 · cited 1×
“However, the use of the LNSC may not be as accurate as previously thought in patients with de novo and recurrent/persistent Cushing disease, as shown by the wide fluctuations in sequentiallymeasured LNSC in a recent prospective analysis [33].”
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma
Ceccato, F., Barbot, M., Albiger, N., Antonelli, G., Zilio, M., Todeschini, M., Regazzo, D., Plebani, M., Lacognata, C., Iacobone, M., et al. (2018) · Endocrine · doi:10.1007/s12020-017-1421-3 · Cited by 38 · cited 2×
“[35], showed that daily cortisol exposure, evaluated using area under the curve from multiple saliva collections, was increased in the morning in patients with adrenal adenomas and a serum cortisol .”
BackgroundDe Bucy, C., Guignat, L., Niati, T., Bertherat, J., & Coste, J. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0048 · Cited by 37 · cited 1×
“early initiation of treatment has been shown to relieve the burden of disease [59, 60].”
BackgroundKann, P., Laudes, M., Piepkorn, B., Heintz, A., & Beyer, J. (2001) · Clinical Rheumatology · doi:10.1007/s100670170099 · Cited by 34
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas
Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Salcuni, A. S., Scillitani, A., Carnevale, V., Corbetta, S., Arosio, M., Della Casa, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1423 · Cited by 33
Self-citationFriedman, T. C., Ghods, D. E., Shahinian, H. K., Zachery, L., Shayesteh, N., Seasholtz, S., Zuckerbraun, E., Lee, M. L., & McCutcheon, I. E. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1263128 · Cited by 31 · cited 1×
“In fact, some authors have suggested that multiple tests may be the best approach to diagnose hypercortisolism accurately [58].”
BackgroundEldeiry, L. S., & Garber, J. R. (2008) · Endocrine Practice · doi:10.4158/ep.14.3.279 · Cited by 28 · cited 1×
“However, adherence to such guidelines is inadequate, with only 30% of patients with adrenal adenomas referred for hormonal workup [13].”
BackgroundCosta, D., Conceição, F. L., Leite, N. C., Ferreira, M. T., Salles, G. F., & Cardoso, C. R. L. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.006 · Cited by 26
Screening for Cushing Syndrome at the Primary Care Level: What Every General Practitioner Must Know
Yorke, E., Atiase, Y., Akpalu, J., & Sarfo‐Kantanka, O. (2017) · International Journal of Endocrinology · doi:10.1155/2017/1547358 · Cited by 26 · cited 2×
“However, high fluid intake, contamination, incomplete urine collection, certain drugs, and decreased glomerular filtration rate (,60 mL/min) may affect the accuracy of this test [9, 11, 47, 48].”
BackgroundReassessing the reliability of the salivary cortisol assay for the diagnosis of Cushing syndrome
Zhang, Q., Dou, J., Gu, W., Yang, G., & Lu, J. (2013) · Journal of International Medical Research · doi:10.1177/0300060513498017 · Cited by 25 · cited 1×
“Furthermore, the sample can be stored in the refrigerator for several days and mailed to the laboratory at room temperature [11, 38, 39].”
BackgroundPatients' Perception On Clinical Outcome And Quality Of Life After A Diagnosis Of Cushing Syndrome
Papoian, V., Biller, B. M. K., Webb, S. M., Campbell, K. K., Hodin, R. A., & Phitayakorn, R. (2015) · Endocrine Practice · doi:10.4158/ep15855.or · Cited by 24 · cited 1×
“early initiation of treatment has been shown to relieve the burden of disease [59, 60].”
BackgroundWhich type 2 diabetes mellitus patients should be screened for subclinical Cushing’s syndrome?
Cansu, G. B., Atılgan, S., Balcı, M. K., Sarı, R., Özdem, S., & Altunbaş, H. (2017) · HORMONES · doi:10.14310/horm.2002.1716 · Cited by 19
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
Altieri, B., Muscogiuri, G., Paschou, S. Α., Vryonidou, A., Casa, S. D., Pontecorvi, A., Faßnacht, M., Ronchi, C. L., & Newell-Price, J. D. C. (2018) · Endocrine · doi:10.1007/s12020-018-1696-z · Cited by 17 · cited 1×
“A young patient with unexplained osteoporosis or a history of nontraumatic or fragility fractures should also be evaluated, as cortisol plays a major role in the bone and calcium homeostasis [14, 15].”
BackgroundCipoli, D. E., Martínez, E. Z., de Castro, M., & Moreira, A. C. (2012) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302012000900006 · Cited by 14 · cited 1×
“Another study found that, among physicians attending endocrinology meetings, the probability of diagnosing hypercortisolism was based on number of years in practice [56].”
BackgroundSasaki, Y., Katabami, T., Asai, S., Fukuda, H., & Tanaka, Y. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0083 · Cited by 14 · cited 1×
“6 nM) to avoid the possibility of a false-positive result [30].”
BackgroundIn what clinical settings should Cushing's syndrome be suspected?
Bruno, O. D., Juárez‐Allen, L., Rossi, M., & Longobardi, V. (2009) · PubMed · Cited by 10
Raised cortisol excretion rate in urine and contamination by topical steroids
Kelly, C. J., Ogilvie, A., Evans, J. R., Shapiro, D., Wallace, A. M., & Davies, D. L. (2001) · BMJ · doi:10.1136/bmj.322.7286.594 · Cited by 4 · cited 1×
“However, high fluid intake, contamination, incomplete urine collection, certain drugs, and decreased glomerular filtration rate (,60 mL/min) may affect the accuracy of this test [9, 11, 47, 48].”
Cited by
Hair cortisol concentration as a biomarker of parental burnout
Brianda, M. E., Roskam, I., & Mikolajczak, M. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104681 · Cited by 121
Morelli, V., Frigerio, S., Aresta, C., Passeri, E., Pugliese, F., Copetti, M., Barbieri, A. M., Fustinoni, S., Polledri, E., Corbetta, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.898084 · Cited by 68
Self-citationIacopo, C., Falchetti, A., Merlotti, D., Cristina, E.-V., & Gennari, L. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1772051 · Cited by 64
Treatment options for glucocorticoid-induced osteoporosis
Chiodini, I., Merlotti, D., Falchetti, A., & Gennari, L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1721467 · Cited by 48
“If this data is confirmed, drugs able to act on the 11βhydroxysteroid-dehydrogenase enzymes may be developed for curing osteoporosis, not only in patients with GC excess, but also in those cases of high GC sensitivity [114,115].”
BackgroundSelf-citationVogg, N., Kurlbaum, M., Deutschbein, T., Gräsl, B., Fassnacht, M., & Kroiss, M. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab056 · Cited by 38
“there is an ongoing debate about the best test strategy in this setting (12).”
Background
Metadata
- Authors
- Chiodini, I., Ramos-Rivera, A., Marcus, A. O., & Yau, H.
- Affiliations
- University of Milan (IT)
- Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, Florida
- South Orange County Endocrinology, Laguna Hills, California
- University of California, San Francisco (US)
- Corresponding author
- Yau, Hanford
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2019-04-11
- Volume
- 3
- Issue
- 5
- Pages
- 1097-1109
- ISSN
- 2472-1972 (ISSN-L)
- PMC
- PMC6500795
- OpenAlex
- W2939101516
- Cited by
- 25
- References
- 62
- Citations by year
- 2026: 3 · 2025: 3 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 6
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Amgen
- Regeneron Pharmaceuticals
- MannKind Corporation
- Italfarmaco
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal adenoma, biochemical screening, cortisol measurement, diagnostic thresholds, Cushingoid features, screening indications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.